FDA Not Impressed With TransEnterix's SurgiBot 510(k)
This article was originally published in The Gray Sheet
Executive Summary
The company seeking to make waves in the robotic surgery space hit a major speed bump with a finding by FDA that its SurgiBot did not meet substantial equivalence requirements.